1例基因多态性与瑞舒伐他汀疗效个体差异的病例分析

廉洪; 朱逢佳; 关业勍; 刘炜<sup>*</sup>

引用本文:	廉洪,朱逢佳,关业勍,刘炜.1例基因多态性与瑞舒伐他汀疗效个体差异的病例分析[J].中国现代应用药学,2014,31(6):745-748.
	LIAN Hong,ZHU Fengjia,GUAN Yeqing,LIU Wei.A Case Study of the Association Between Genetic Polymorphisms and Interindividual Variation of Response to Rosuvastatin[J].Chin J Mod Appl Pharm(中国现代应用药学),2014,31(6):745-748.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 2621次下载 1802次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
1例基因多态性与瑞舒伐他汀疗效个体差异的病例分析
廉洪¹, 朱逢佳¹, 关业勍², 刘炜¹
1.浙江医院药剂科，杭州 310013;2.浙江大学城市学院医学院，杭州 310015

摘要:

目的探讨一患者服用瑞舒伐他汀后短期降脂疗效减弱的可能原因。方法焦磷酸测序技术检测患者ATP结合转运蛋白超家族成员2 (ABCG2)及有机阴离子转运体1B1(SLCO1B1)基因多态性。结果患者为ABCG2 c.421 CA杂合子，SLCO1B1 c.388GG纯合子，SLCO1B1 c.521TT纯合子。结论 SLCO1B1 c.388G突变有可能与瑞舒伐他汀短期降脂疗效减弱有关。

关键词: 基因多态性个体差异瑞舒伐他汀

DOI：

分类号:

基金项目:浙江省医药卫生科技计划课题(2010KYB016)

A Case Study of the Association Between Genetic Polymorphisms and Interindividual Variation of Response to Rosuvastatin

LIAN Hong¹, ZHU Fengjia¹, GUAN Yeqing², LIU Wei¹

1.Department of Pharmacy, Zhejiang Hospital, Hangzhou 310013, China;2.Zhejiang University City College, School of Medicine, Hangzhou 310015, China

Abstract:

OBJECTIVE To explore the possible reason of that a patient had decreased short-term lipid-lowering response to rosuvastatin. METHODS The patient’s ATP-binding cassette G2 (ABCG2) and organic anion transporter 1B1 (SLCO1B1) gene polymorphisms was detected. Pyrosequencing technology was used to detect gene polymorphisms. RESULTS The patient was ABCG2 c.421 CA heterozygous, SLCO1B1 c.388GG homozygous, SLCO1B1 c.521TT homozygous. CONCLUSION SLCO1B1 c.388G mutation may be related to decreased short-term lipid-lowering response to rosuvastatin.

Key words: genetic polymorphism interindividual variation rosuvastain